Name: Latest research reports of Ajanta Pharma Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Expensive Performer

2714.1000 87.75 (3.34%)

NSE Mar 21, 2025 15:31 PM

32.29% Gain from 52W Low

Volume: 1.1M

High volume today

Ajanta Pharma Ltd.

11 May 2022

2714.10

3.34%

Ajanta Pharma (BUY): Margin stress continues

Buy: Ajanta Pharma Ltd.

Target

BOB Capital Markets Ltd.

Q4 revenue 6% ahead of our estimate but margins disappointed with gross/EBITDA margin contraction of 530bps/1050bps YoY to ~72%/24%

Ajanta Pharma Ltd. has gained 30.35% in the last 1 Year